Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$53,216
-$8,840 QoQ
Shares Held
2,210
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,615
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Front Row Advisors LLC holds $11,088,191 across 9 Drug Manufacturers - General names. PFE ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,207 | $6,091,449 | |
| 2 | AMGN |
Amgen Inc
|
8,625 | $3,123,285 | |
| 3 | JNJ |
Johnson & Johnson
|
4,871 | $1,237,087 | |
| 4 | LLY |
ELI LILLY & Co
|
287 | $344,236 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,497 | $189,130 | |
| 6 | PFE |
Pfizer Inc
This page
|
2,210 | $53,216 | |
| 7 | MRK |
Merck & Co., Inc.
|
297 | $38,164 | |
| 8 | GSK |
GSK plc
|
221 | $11,584 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,216 | 2,210 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $62,056 | 2,210 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $55,029 | 2,210 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $56,310 | 2,210 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $53,570 | 2,210 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $104,831 | 4,137 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $109,489 | 4,127 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $176,476 | 6,098 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $380,891 | 13,613 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $335,941 | 12,106 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,571,271 | 54,577 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $2,140,028 | 64,517 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,359,257 | 64,320 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,605,896 | 63,870 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $3,291,965 | 64,246 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,914,984 | 66,613 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $3,498,811 | 66,733 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,465,742 | 66,945 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,845,276 | 65,119 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $2,832,036 | 65,846 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $2,575,161 | 65,760 | Shares | Sole | 2021-08-23 | |
| 2021-03-31 | $2,006,562 | 55,384 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,012,586 | 54,675 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $2,044,665 | 55,713 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $1,875,183 | 57,345 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,900,363 | 58,222 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||